feed,title,long_url,short_url
Benzinga,Vertex Pharma's Trikafta Triplet Therapy Wins FDA Approval For Expanded Use In Children 6-11 Years With Cystic Fibrosis,https://benzinga.com/general/biotech/21/06/21490462/vertex-pharmas-trikafta-triplet-therapy-wins-fda-approval-for-expanded-use-in-children-6-11-years,https://j.mp/3532buB
Benzinga,"SQZ Biotechnologies' TAC Program Induces Multiple Mechanisms Of Antigen-Specific Tolerance, Animal Study Shows",https://benzinga.com/general/biotech/21/06/21489862/sqz-biotechnologies-tac-program-induces-multiple-mechanisms-of-antigen-specific-tolerance-animal-,https://j.mp/3pNaKn7
